Inovalon Holdings Inc. (NASDAQ:INOV) Director William D. Green acquired 30,000 shares of Inovalon Holdings stock in a transaction that occurred on Friday, September 16th. The shares were purchased at an average cost of $16.22 per share, for a total transaction of $486,600.00. Following the purchase, the director now directly owns 38,351 shares of the company’s stock, valued at approximately $622,053.22. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Inovalon Holdings Inc. (NASDAQ:INOV) opened at 15.70 on Thursday. Inovalon Holdings Inc. has a 52 week low of $13.85 and a 52 week high of $23.87. The stock has a 50 day moving average of $15.56 and a 200-day moving average of $17.51. The stock has a market cap of $2.39 billion, a P/E ratio of 53.04 and a beta of 1.06.

Inovalon Holdings (NASDAQ:INOV) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.14. The company had revenue of $123.80 million for the quarter, compared to analysts’ expectations of $126.86 million. Inovalon Holdings had a net margin of 9.88% and a return on equity of 7.51%. The business’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.18 EPS. Analysts forecast that Inovalon Holdings Inc. will post $0.42 earnings per share for the current year.

Several equities analysts recently issued reports on INOV shares. Goldman Sachs Group Inc. downgraded shares of Inovalon Holdings from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $25.00 to $17.00 in a research note on Thursday, August 4th. Zacks Investment Research downgraded shares of Inovalon Holdings from a “hold” rating to a “sell” rating in a research note on Tuesday, August 9th. Citigroup Inc. cut their price target on shares of Inovalon Holdings from $18.00 to $17.00 and set a “neutral” rating on the stock in a research note on Thursday, August 4th. KeyCorp cut their price target on shares of Inovalon Holdings from $26.00 to $20.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 16th. Finally, TheStreet downgraded shares of Inovalon Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, August 24th. Four equities research analysts have rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $18.50.

Institutional investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. boosted its position in shares of Inovalon Holdings by 26.7% in the first quarter. Goldman Sachs Group Inc. now owns 263,103 shares of the company’s stock valued at $4,873,000 after buying an additional 55,440 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in shares of Inovalon Holdings by 76.9% in the first quarter. UBS Asset Management Americas Inc. now owns 19,100 shares of the company’s stock valued at $354,000 after buying an additional 8,300 shares in the last quarter. State Street Corp boosted its position in shares of Inovalon Holdings by 17.2% in the first quarter. State Street Corp now owns 344,556 shares of the company’s stock valued at $6,380,000 after buying an additional 50,572 shares in the last quarter. Tiverton Asset Management LLC acquired a new position in shares of Inovalon Holdings during the first quarter valued at about $2,539,000. Finally, TLP Group LLC acquired a new position in shares of Inovalon Holdings during the second quarter valued at about $150,000. 32.04% of the stock is currently owned by institutional investors.

About Inovalon Holdings

Inovalon Holdings, Inc is a technology company. The Company combines advanced cloud-based data analytics and data-driven intervention platforms to provide services for health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. The Company operates through developing cloud-based data analytics and data-driven intervention platforms segment and provides related services to its clients.

5 Day Chart for NASDAQ:INOV

Receive News & Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.